COMPANY NAME]Investment Rights Agreement • December 30th, 2022 • California
By execution of this letter agreement (this “Agreement”), the undersigned Company agrees that FlashFunders Securities, LLC, or its permitted assigns (“Investor”), is entitled to subscribe for and purchase from the Company the Securities at the Purchase Price, on the terms and conditions set forth in this Agreement. Certain capitalized terms are defined on the attached Exhibit A.
VISCARIA LIMITED c/o Aspen Secretarial Services Lemesou, 77 Elia House Attention: Devora Har-Tuv Facsimile: +357 2241 8801 May 14, 2012Investment Rights Agreement • May 15th, 2012 • Apax Europe VII-A, L.P. • Services-computer programming services • New York
INVESTMENT RIGHTS AGREEMENTInvestment Rights Agreement • May 26th, 2017 • Jaguar Animal Health, Inc. • Pharmaceutical preparations
Exhibit 4.11 INVESTMENT RIGHTS AGREEMENT This Investment Rights Agreement (this "Agreement") is made and entered into as of March 31, 2004, by and among Cytomedix, Inc. (the "Company") and the undersigned Purchaser ("Purchaser"). This Agreement is...Investment Rights Agreement • May 11th, 2004 • Cytomedix Inc • Services-commercial physical & biological research
INVESTMENT RIGHTS AGREEMENT This Investment Rights Agreement (this "Agreement") dated as of December 4, 1998 is entered into by and between SmarTalk TeleServices, Inc., a California corporation (together with its successors, "SmarTalk"), and Fletcher...Investment Rights Agreement • December 9th, 1998 • Smartalk Teleservices Inc • Communications services, nec • Delaware
Investment Rights AgreementInvestment Rights Agreement • March 29th, 2021 • GX Acquisition Corp. • Pharmaceutical preparations • Delaware
This Investment Rights Agreement (this “Agreement”) is made as of the 15th day of August, 2017, by and between Celularity, Inc., a Delaware corporation (“Celularity”), and Celgene Corporation, a Delaware corporation (“Celgene”).
INVESTMENT RIGHTS AGREEMENTInvestment Rights Agreement • May 26th, 2017 • Jaguar Animal Health, Inc. • Pharmaceutical preparations
